European health systems show clear weaknesses in how they govern artificial intelligence, according to a study presented at HIMSS26 Europe on July 14, 2026. The findings have pushed the World Health Organization's European regional office to speed up work on a roadmap to help member states tighten oversight of AI tools in clinical and population health settings.
David Novillo Ortiz, with the WHO European regional office, described the agency's plan to develop the guidance. The roadmap targets gaps the study identified, including challenges with interoperability, policy alignment, and clear accountability for decisions informed by AI systems.
Gaps in AI governance
The study examined AI governance across multiple European health systems. It found that many countries lack consistent frameworks for evaluating AI tools before and after deployment. Issues with data sharing between systems and unclear lines of responsibility for algorithmic outcomes surfaced repeatedly.
These weaknesses leave health systems exposed to risks such as biased clinical recommendations or disjointed patient data handling. Without stronger oversight, the benefits of AI-faster diagnostics or population health insights-are harder to achieve safely.
WHO's planned roadmap
Ortiz said the roadmap will offer practical steps for national health authorities to build or refine their AI governance structures. The work aligns with broader WHO efforts to set standards for ethical AI in health. For health systems and policy teams seeking to strengthen their own processes, resources like the AI Learning Path for Policy Makers provide structured training on AI oversight and regulation.
The European region's push comes as AI adoption accelerates in healthcare, from radiology to administrative workflows. The roadmap is expected to address both technical and legal dimensions, helping countries adapt existing regulations to AI-specific challenges.
Why this matters for healthcare professionals
Healthcare staff on the ground-clinicians, IT leaders, and administrators-are the ones who will work with AI tools daily. Weak governance means these tools may enter clinical use without proper validation, creating safety and liability concerns. Knowing the governance gaps and the coming standards allows professionals to ask the right questions before adopting AI in their own organizations. Staying current with AI developments through resources such as AI for Healthcare can help teams prepare for more rigorous oversight requirements.
Your membership also unlocks:
